Wilmington Funds Management’s Boston Scientific BSX Stock Holding History

Wilmington Funds Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$231K	Sell	18,100 -13,500	-43%	-$176K	0.02%	620
2014 Q1	$427K	Hold	31,600	–	–	0.05%	407
2013 Q4	$380K	Hold	31,600	–	–	0.04%	480
2013 Q3	$371K	Sell	31,600 -10,700	-25%	-$116K	0.04%	479
2013 Q2	$392K	Buy	+42,300	New	+$359K	0.04%	445

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wilmington Funds Management's BSX Position: Q2 2014 in Review

Wilmington Funds Management reduced its Boston Scientific (BSX) stake by 43% in Q2 2014, selling an estimated $176K and leaving 18,100 shares worth $231K. The position accounts for 0.02% of the portfolio, ranked #620.

Wilmington Funds Management first reported a position in BSX in Q2 2013 and has held it in 5 quarters since. The position peaked at $427K in Q1 2014. 458 funds tracked by Wall St. Rank hold BSX as of Q2 2014.

Wilmington Funds Management held 18,100 shares of Boston Scientific worth $231K as of Q2 2014.
Wilmington Funds Management sold 13,500 Boston Scientific shares in Q2 2014, an estimated $176K.
Boston Scientific made up 0.02% of Wilmington Funds Management's portfolio in Q2 2014, its #620 holding.
Wilmington Funds Management first reported a position in Boston Scientific in Q2 2013 and has held it in 5 quarters since.
Wilmington Funds Management's Boston Scientific position peaked at $427K in Q1 2014.
458 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.